Literature DB >> 17524117

Contrast-induced nephropathy remains a serious complication of PCI.

Roxana Mehran1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17524117     DOI: 10.1111/j.1540-8183.2007.00260.x

Source DB:  PubMed          Journal:  J Interv Cardiol        ISSN: 0896-4327            Impact factor:   2.279


× No keyword cloud information.
  9 in total

Review 1.  Comparative efficacy of pharmacological interventions for contrast-induced nephropathy prevention after coronary angiography: a network meta-analysis from randomized trials.

Authors:  Wen-Qi Ma; Yu Zhao; Ying Wang; Xi-Qiong Han; Yi Zhu; Nai-Feng Liu
Journal:  Int Urol Nephrol       Date:  2018-02-05       Impact factor: 2.370

2.  Effects of hydration combined with Shenfu injection on contrast-induced acute kidney injury in acute coronary syndrome patients undergoing percutaneous coronary intervention.

Authors:  Zhen Guo; Dandan Niu; Yaren Yu; Di Zhen; Wenhua Li
Journal:  Biomed Rep       Date:  2017-09-22

3.  Urinary kidney injury molecule-1 as an early indicator to predict contrast-induced acute kidney injury in patients with diabetes mellitus undergoing percutaneous coronary intervention.

Authors:  Wenhua Li; Yaren Yu; Haiyan He; Jing Chen; Debin Zhang
Journal:  Biomed Rep       Date:  2015-04-16

4.  Prevention of contrast-induced nephropathy with prostaglandin E1 in high-risk patients undergoing percutaneous coronary intervention.

Authors:  Wen-Hua Li; Dong-Ye Li; Wen-Hao Qian; Jia-Li Liu; Tong-Da Xu; Hong Zhu; Hai-Yan He
Journal:  Int Urol Nephrol       Date:  2014-02-26       Impact factor: 2.370

5.  A comparison of sodium bicarbonate infusion versus normal saline infusion and its combination with oral acetazolamide for prevention of contrast-induced nephropathy: a randomized, double-blind trial.

Authors:  Maryam Pakfetrat; Mohammad Hossein Nikoo; Leila Malekmakan; Mahmood Tabandeh; Jamshid Roozbeh; Mahshid Hashemi Nasab; Mohammad Ali Ostovan; Soheila Salari; Mohammad Kafi; Najmeh Moin Vaziri; Farzad Adl; Mehdi Hosseini; Parviz Khajehdehi
Journal:  Int Urol Nephrol       Date:  2009-01-10       Impact factor: 2.370

6.  Atorvastatin combining with probucol: a new way to reduce serum uric acid level during perioperative period of interventional procedure.

Authors:  Hong Li; Ximing Li; Hongjun Ma; Yiran Wang; Naikuan Fu; Dongxia Jin; Hongliang Cong
Journal:  ScientificWorldJournal       Date:  2014-01-29

7.  Efficacy of alprostadil for preventing of contrast-induced nephropathy: A meta-analysis.

Authors:  Jing-Zhan Zhang; Xiao-Jing Kang; Ying Gao; Ying-Ying Zheng; Ting-Ting Wu; Long Li; Fen Liu; Yi-Ning Yang; Xiao-Mei Li; Yi-Tong Ma; Xiang Xie
Journal:  Sci Rep       Date:  2017-04-21       Impact factor: 4.379

8.  Periprocedural myocardial and renal injury in patients undergoing elective percutaneous coronary interventions - is there an association?

Authors:  Mario Stipinovic; Luka Percin; Vedran Radonic; Helena Jerkic; Ivana Jurin; Tomislav Letilovic
Journal:  Medicine (Baltimore)       Date:  2019-10       Impact factor: 1.817

9.  The predictive value of the product of contrast medium volume and urinary albumin/creatinine ratio in contrast-induced acute kidney injury.

Authors:  Chunrui Wang; Shuai Ma; Bo Deng; Jianxin Lu; Wei Shen; Bo Jin; Haiming Shi; Feng Ding
Journal:  Ren Fail       Date:  2017-11       Impact factor: 2.606

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.